Okabena Investment Services Inc. Decreases Position in The Clorox Company (NYSE:CLX)

Okabena Investment Services Inc. trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 10.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,091 shares of the company’s stock after selling 811 shares during the period. Okabena Investment Services Inc.’s holdings in Clorox were worth $1,155,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Cerity Partners LLC grew its position in Clorox by 13.5% during the 3rd quarter. Cerity Partners LLC now owns 52,454 shares of the company’s stock worth $8,545,000 after acquiring an additional 6,232 shares during the last quarter. Nwam LLC purchased a new stake in shares of Clorox during the third quarter valued at approximately $289,000. Meridian Wealth Management LLC bought a new position in shares of Clorox in the third quarter worth approximately $431,000. Studio Investment Management LLC purchased a new position in shares of Clorox in the third quarter worth $419,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Clorox by 1.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after acquiring an additional 13,038 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.57% of the stock is currently owned by company insiders.

Clorox Stock Up 0.1 %

NYSE CLX opened at $169.30 on Friday. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.35. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $20.96 billion, a P/E ratio of 58.99, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41. The stock’s 50-day moving average price is $162.78 and its 200-day moving average price is $148.48.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue was up 27.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.49 EPS. On average, equities research analysts predict that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.04%.

Analyst Ratings Changes

CLX has been the subject of a number of recent research reports. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Barclays increased their price objective on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. DA Davidson boosted their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Finally, JPMorgan Chase & Co. upped their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of “Hold” and an average target price of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.